Suchergebnisse - "Lian, Hong-Yun"

PubPharm (18)

1

The plasma-soluble CSF1R level is a promising prognostic indicator for pediatric Langerhans cell histiocytosis

enthalten in: Pediatric blood & cancer | 2024

von Zhu, T. | Wang, C. | Lian, H. | +6

2

The plasma‐soluble CSF1R level is a promising prognostic indicator for pediatric Langerhans cell histiocytosis

enthalten in: Pediatric Blood & Cancer | 2024

von Zhu, T. | Wang, C. | Lian, H. | +6

3

Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children : Results from the BCH-LCH 2014 protocol study

enthalten in: American journal of hematology | 2023

von Cui, L. | Wang, C. | Lian, H. | +12

4

Characteristics and Treatment Outcomes of Pediatric Langerhans Cell Histiocytosis with Thymic Involvement

enthalten in: The Journal of pediatrics | 2022

von Yao, J. | Wang, D. | Ma, H. | +7

5

Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis

enthalten in: Orphanet journal of rare diseases | 2022

von Wang, D. | Chen, X. | Wei, A. | +14

6

Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis

enthalten in: Orphanet journal of rare diseases | 2022

von Wang, D. | Chen, X. | Wei, A. | +14

7

Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis

enthalten in: Orphanet journal of rare diseases | 2022

von Wang, D. | Chen, X. | Wei, A. | +14

8

Significance of serum Th1/Th2 cytokine levels in underlying disease classification of childhood HLH

enthalten in: Cytokine | 2022

von Zhao, X. | Lian, H. | Zhang, L. | +8

9

BRAF V600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis

enthalten in: Molecular cancer therapeutics | 2021

von Wang, C. | Cui, L. | Ma, H. | +8

10

A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis

enthalten in: Haematologica | 2021

von Zhang, Q. | Wei, A. | Ma, H. | +10